πŸ‡ΊπŸ‡Έ FDA
Patent

US 8501964

Serotonin reuptake inhibitors

granted A61KA61K31/40A61K31/41

Quick answer

US patent 8501964 (Serotonin reuptake inhibitors) held by Theravance, Inc. expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/40, A61K31/41, A61K31/4155, A61K31/4178